Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,745 | 30,594 | 82,806 | 13,463 | 85,530 |
| Marketable Securities | 17,588 | 13,159 | N/A | N/A | 104,098 |
| Receivables | 5,985 | 5,851 | 3,665 | 2,266 | 4,596 |
| Inventories | 4,025 | 2,200 | 2,368 | 601 | N/A |
| TOTAL | $30,351 | $55,092 | $93,184 | $17,181 | $203,615 |
| Non-Current Assets | |||||
| PPE Net | 7,300 | 6,861 | 3,456 | 689 | 12,539 |
| Intangibles | 4,864 | 16,768 | 16,727 | 5,822 | 106,895 |
| Other Non-Current Assets | 27,896 | 2,641 | 2,890 | 3,171 | 13,152 |
| TOTAL | $40,060 | $26,270 | $23,073 | $9,682 | $132,586 |
| Total Assets | $70,411 | $81,362 | $116,257 | $26,863 | $336,201 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,284 | 1,295 | 2,499 | 1,191 | 15,968 |
| Accrued Expenses | 2,142 | 5,858 | 3,849 | 1,470 | 7,072 |
| Other current liabilities | 92 | 373 | 335 | 22 | N/A |
| TOTAL | $8,184 | $13,498 | $9,733 | $5,625 | $41,670 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,269 | 19,649 | 14,088 | 3,353 | N/A |
| Deferred Revenues | 338 | 3,958 | 205 | 606 | 18,100 |
| Other Non-Current Liabilities | 56,478 | 1,478 | 1,502 | 43,223 | 115,739 |
| TOTAL | $61,989 | $21,299 | $15,740 | $46,697 | $140,995 |
| Total Liabilities | $70,173 | $34,797 | $25,473 | $52,322 | $182,665 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,674 | 1,648 | 1,631 | N/A | 60,029 |
| Common Shares | 5 | 5 | 5 | 2 | 60 |
| Retained earnings | -161,465 | -113,741 | -65,270 | -26,312 | -359,496 |
| Other shareholders' equity | 0 | -3 | 0 | 0 | 741 |
| TOTAL | $238 | $46,565 | $90,784 | $-25,459 | $153,536 |
| Total Liabilities And Equity | $70,411 | $81,362 | $116,257 | $26,863 | $336,201 |